KSNR Clinical Consensus Statements: Rehabilitation of Patients with Parkinson's Disease

키워드

참고문헌 (84)

1. Keus SH, "Improving community healthcare for patients with Parkinson's disease : the Dutch model", Parkinsons Dis, 2012, pp.543426~ (2012)
2. Miller N, "Life with communication changes in Parkinson's disease", Age Ageing, 35, pp.235~239 (2006)
3. Rosenfeld RM, "Clinical consensus statement development manual", Otolaryngol Head Neck Surg, 153, pp.S1~S14 (2015)
4. Olesen J, "The economic cost of brain disorders in Europe", Eur J Neurol, 19, pp.155~162 (2012)
5. von Campenhausen S, "Prevalence and incidence of Parkinson's disease in Europe", Eur Neuropsychopharmacol, 15, pp.473~490 (2005)
6. Gelb DJ, "Diagnostic criteria for Parkinson disease", Arch Neurol, 56, pp.33~39 (1999)
7. Martignoni E, "Comorbid disorders and hospitalisation in Parkinson's disease : a prospective study", Neurol Sci, 25, pp.66~71 (2004)
8. Evans JR, "The natural history of treated Parkinson's disease in an incident, community based cohort", J Neurol Neurosurg Psychiatry, 82, pp.1112~1118 (2011)
9. Sato K, "Prognosis of Parkinson's disease : time to stage III, IV, V, and to motor fluctuations", Mov Disord, 21, pp.1384~1395 (2006)
10. García-Ruiz PJ, "What factors influence motor complications in Parkinson disease? : a 10-year prospective study", Clin Neuropharmacol, 35, pp.1~5 (2012)
11. Schrag A, "Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism", Lancet Neurol, 5, pp.355~363 (2006)
12. Thenganatt MA, "Parkinson disease subtypes", JAMA Neurol, 71, pp.499~504 (2014)
13. Goetz CG, "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results", Mov Disord, 23, pp.2129~2170 (2008)
14. Keus SHJ, "European Physiotherapy Guideline for Parkinson's disease", pp.2014, KNGF
15. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care, "National Collaborating Centre for Chronic Conditions", Royal College of Physicians, ~ (2006)
16. Cartmill C, "Transdisciplinary teamwork : the experience of clinicians at a functional restoration program", J Occup Rehabil, 21, pp.1~8 (2011)
17. Lord S, "Ambulatory activity in incident Parkinson's : more than meets the eye", J Neurol, 260, pp.2964~2972 (2013)
18. National Institute for Health and Care Excellence, "Parkinson's disease in adults: diagnosis and management" (2017), National Institute for Health and Care Excellence
19. Rizzo G, "Accuracy of clinical diagnosis of Parkinson disease : a systematic review and meta-analysis", Neurology, 86, pp.566~576 (2016)
20. Mak MK, "Long-term effects of exercise and physical therapy in people with Parkinson disease", Nat Rev Neurol, 13, pp.689~703 (2017)
21. Curtze C, "Levodopa is a double-edged sword for balance and gait in people with Parkinson's disease", Mov Disord, 30, pp.1361~1370 (2015)
22. van der Marck MA, "Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease", Parkinsonism Relat Disord, 20, pp.360~369 (2014)
23. Grimes D, "Canadian guidelines on Parkinson's disease", Can J Neurol Sci, 39, pp.S1~S30 (2012)
24. Tomlinson CL, "Physiotherapy for Parkinson's disease: a comparison of techniques", Cochrane Database Syst Rev, pp.CD002815~ (2014)
25. Duncan RP, "Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease", Neurorehabil Neural Repair, 26, pp.132~143 (2012)
26. Wood BH, "Incidence and prediction of falls in Parkinson's disease : a prospective multidisciplinary study", J Neurol Neurosurg Psychiatry, 72, pp.721~725 (2002)
27. van der Heeden JF, "Postural instability and gait are associated with severity and prognosis of Parkinson disease", Neurology, 86, pp.2243~2250 (2016)
28. Bohnen NI, "Postural control, gait, and dopamine functions in parkinsonian movement disorders", Clin Geriatr Med, 22, pp.797~812 (2006)
29. Boonstra TA, "Gait disorders and balance disturbances in Parkinson's disease : clinical update and pathophysiology", Curr Opin Neurol, 21, pp.461~471 (2008)
30. Nonnekes J, "Compensation strategies for gait impairments in Parkinson disease : a review", JAMA Neurol, 76, pp.718~725 (2019)
31. van der Kolk NM, "Effects of exercise on mobility in people with Parkinson's disease", Mov Disord, 28, pp.1587~1596 (2013)
32. Santos SM, "Balance versus resistance training on postural control in patients with Parkinson's disease: a randomized controlled trial", Eur J Phys Rehabil Med, 53, pp.173~183 (2017)
33. Cano Porras D, "Advantages of virtual reality in the rehabilitation of balance and gait : Systematic review", Neurology, 90, pp.1017~1025 (2018)
34. Pérez de la Cruz S, "Effectiveness of aquatic therapy for the control of pain and increased functionality in people with Parkinson's disease: a randomized clinical trial", Eur J Phys Rehabil Med, 53, pp.825~832 (2017)
35. Silva AZ, "Effects of dual-task aquatic exercises on functional mobility, balance and gait of individuals with Parkinson's disease : a randomized clinical trial with a 3-month follow-up", Complement Ther Med, 42, pp.119~124 (2019)
36. Cheng FY, "Effects of curved-walking training on curved-walking performance and freezing of gait in individuals with Parkinson's disease : a randomized controlled trial", Parkinsonism Relat Disord, 43, pp.20~26 (2017)
37. Di Martino S, "Aerobic rehabilitation program for improving muscle function in Parkinson's disease", Restor Neurol Neurosci, 36, pp.13~20 (2018)
38. Dockx K, "Virtual reality for rehabilitation in Parkinson's disease", Cochrane Database Syst Rev, 12, pp.CD010760~ (2016)
39. Volpe D, "A comparison of Irish set dancing and exercises for people with Parkinson's disease : a phase II feasibility study", BMC Geriatr, 13, pp.54~ (2013)
40. Berra E, "Body weight support combined with treadmill in the rehabilitation of parkinsonian gait : a review of literature and new data from a controlled study", Front Neurol, 9, pp.1066~ (2019)
41. Dixon L, "Occupational therapy for patients with Parkinson's disease", Cochrane Database Syst Rev, 2007, pp.CD002813~ (2007)
42. Sturkenboom IHWM, "Guidelines for occupational therapy in Parkinson's disease rehabilitation", pp.2011, The Netherlands
43. Ni M, "Exercise guidelines for gait function in Parkinson's disease : a systematic review and meta-analysis", Neurorehabil Neural Repair, 32, pp.872~886 (2018)
44. Fox C, "LSVT LOUD and LSVT BIG : behavioral treatment programs for speech and body movement in Parkinson disease", Parkinsons Dis, 2012, pp.391946~ (2012)
45. Fishel SC, "The impact of LSVT BIG therapy on postural control for individuals with Parkinson disease: a case series", Physiother Theory Pract (2018)
46. Ebersbach G, "Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study", Mov Disord, 25, pp.1902~1908 (2010)
47. Jankovic J, "Functional decline in Parkinson disease", Arch Neurol, 58, pp.1611~1615 (2001)
48. Hariz GM, "Activities of daily living and quality of life in persons with newly diagnosed Parkinson's disease according to subtype of disease, and in comparison to healthy controls", Acta Neurol Scand, 123, pp.20~27 (2011)
49. Sturkenboom IH, "Efficacy of occupational therapy for patients with Parkinson's disease : a randomised controlled trial", Lancet Neurol, 13, pp.557~566 (2014)
50. Radder DL, "Physical therapy and occupational therapy in Parkinson's disease", Int J Neurosci, 127, pp.930~943 (2017)
51. Simons JA, "Swallowing dysfunctions in Parkinson's disease", Int Rev Neurobiol, 134, pp.1207~1238 (2017)
52. Manor Y, "Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease", Mov Disord, 22, pp.1917~1921 (2007)
53. Simons JA, "Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson's disease", Parkinsonism Relat Disord, 20, pp.992~998 (2014)
54. Suiter DM, "Clinical utility of the 3-ounce water swallow test", Dysphagia, 23, pp.244~250 (2008)
55. Langmore SE, "Evaluation of oropharyngeal dysphagia : which diagnostic tool is superior", Curr Opin Otolaryngol Head Neck Surg, 11, pp.485~489 (2003)
56. Logemann JA, "Dysphagia : evaluation and treatment", Folia Phoniatr Logop, 47, pp.140~164 (1995)
57. Carlson DA, "High-resolution manometry in clinical practice", Gastroenterol Hepatol(N Y), 11, pp.374~384 (2015)
58. McCulloch TM, "High-resolution manometry of pharyngeal swallow pressure events associated with head turn and chin tuck", Ann Otol Rhinol Laryngol, 119, pp.369~376 (2010)
59. Kalf JG, "Prevalence of oropharyngeal dysphagia in Parkinson's disease : a meta-analysis", Parkinsonism Relat Disord, 18, pp.311~315 (2012)
60. Kelly B, "Acute hospital admissions of individuals with a known Parkinson's disease diagnosis in Ireland 2009–2012 : a short report", J Parkinsons Dis, 6, pp.709~716 (2016)
61. Low V, "Measuring the burden and mortality of hospitalisation in Parkinson's disease : a cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013", Parkinsonism Relat Disord, 21, pp.449~454 (2015)
62. Pennington S, "The cause of death in idiopathic Parkinson's disease", Parkinsonism Relat Disord, 16, pp.434~437 (2010)
63. Kalf JG, "Guidelines for speech-language therapy in Parkinson's disease", pp.2011, ParkinsonNet
64. El Sharkawi A, "Swallowing and voice effects of Lee Silverman Voice Treatment(LSVT) : a pilot study", J Neurol Neurosurg Psychiatry, 72, pp.31~36 (2002)
65. Miles A, "Effect of Lee Silverman Voice Treatment(LSVT LOUD®)on swallowing and cough in Parkinson's disease : a pilot study", J Neurol Sci, 383, pp.180~187 (2017)
66. Baijens LW, "Surface electrical stimulation in dysphagic Parkinson patients : a randomized clinical trial", Laryngoscope, 123, pp.E38~E44 (2013)
67. Heijnen BJ, "Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson's disease and oropharyngeal dysphagia : effects on quality of life", Dysphagia, 27, pp.336~345 (2012)
68. Troche MS, "Aspiration and swallowing in Parkinson disease and rehabilitation with EMST : a randomized trial", Neurology, 75, pp.1912~1919 (2010)
69. Manor Y, "Video-assisted swallowing therapy for patients with Parkinson's disease", Parkinsonism Relat Disord, 19, pp.207~211 (2013)
70. Sapir S, "Voice and speech abnormalities in Parkinson disease : relation to severity of motor impairment, duration of disease, medication, depression, gender, and age", J Med Speech Lang Pathol, 9, pp.213~226 (2001)
71. Logemann JA, "Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients", J Speech Hear Disord, 43, pp.47~57 (1978)
72. Barnish MS, "Speech and communication in Parkinson's disease : a cross-sectional exploratory study in the UK", BMJ Open, 7, pp.e014642~ (2017)
73. Muller A, "Therapy outcome measures speech language pathology", Folia Phoniatr Logop, 50, pp.220~221 (1998)
74. Perry A, "Therapy outcome measures for allied health practitioners in Australia : the AusTOMs", Int J Qual Health Care, 16, pp.285~291 (2004)
75. Dejonckere PH, "A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS)", Eur Arch Otorhinolaryngol, 258, pp.77~82 (2001)
76. Ramig LO, "Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease", J Speech Hear Res, 39, pp.798~807 (1996)
77. Trail M, "Speech treatment for Parkinson's disease", NeuroRehabilitation, 20, pp.205~221 (2005)
78. Parkinson's Disease Society, "Life with Parkinson's today - room for improvement: results of the UK's largest ever survey of people with Parkinson's and carers" (2008), Parkinson's Disease Society
79. "Working Group of the Clinical Practice Guideline for the Management of Patients with Parkinson's Disease", Ministry of Health, Social Services and Equality; Institute of Health Sciences of Aragon, ~ (2014)
80. Ramig L, "Speech treatment in Parkinson's disease : randomized controlled trial(RCT)", Mov Disord, 33, pp.1777~1791 (2018)
81. Ramig LO, "Intensive voice treatment(LSVT)for patients with Parkinson's disease : a 2 year follow up", J Neurol Neurosurg Psychiatry, 71, pp.493~498 (2001)
82. Atkinson-Clement C, "Behavioral treatments for speech in Parkinson's disease : meta-analyses and review of the literature", Neurodegener Dis Manag, 5, pp.233~248 (2015)
83. Herd CP, "Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease", Cochrane Database Syst Rev, 2012 (2012)
84. Herd CP, "Comparison of speech and language therapy techniques for speech problems in Parkinson's disease", Cochrane Database Syst Rev, 2012 (2012)